The dvm360® feline medicine page is a comprehensive resource for clinical news and insights on the latest veterinary feline medicine This page consists of videos, interviews, articles, podcasts, and research on advancements and developments of therapies for feline medicine, and more.
The bexagliflozin product (Bexacat; Increvet Inc) is also the first SGLT2 inhibitor new animal drug approved by the FDA in any animal species.
Uroliths are one potential cause of lower urinary tract signs in cats. Management varies by type but can be guided by clinical suspicion based on appropriate history, signalment, and diagnostics.
Use of pre-visit pharmaceuticals and in-clinic sedation for feline patients can improve the patient, client, and veterinary experience
Taking cues from a feline can help improve a veterinary visit and behavior at home
The foundation is hoping to move beyond trap/neuter/release programs